| Schedule of antidilutive securities |
| | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | Shares underlying options and warrants outstanding | | | 625,000 | | | | 625,000 | | | | 625,000 | | | | 625,000 | | Shares underlying convertible notes outstanding | | | 5,879,923,509 | | | | 109,269,537,933 | | | | 25,234 | | | | 109,269,537,933 | | Shares underlying convertible preferred stock outstanding | | | 38,909,722 | | | | 16,687,500 | | | | 38,909,722 | | | | 16,687,500 | | Total | | | 5,919,458,231 | | | | 109,286,850,433 | | | | 39,559,956 | | | | 109,286,850,433 | |
|
| Schedule of diluted loss per share |
| | Three Months Ended September 30, 2026 | | | Nine Months Ended September 30, 2026 | | Net income (loss) | | $ | (524,250 | ) | | $ | 56,276,262 | | Less: cumulative dividends on Series E preferred stock | | | (534 | ) | | | (604 | ) | Net income (loss) available to common shareholders | | | (524,784 | ) | | | 56,275,658 | | Less: income attributable to convertible notes | | | | | | | | | Change in fair value of derivative liability | | | - | | | | (60,028,519 | ) | Gain on conversion of debt | | | - | | | | - | | Add: expense attributable to convertible notes | | | | | | | | | Interest expense | | | - | | | | 1,220,500 | | Amortization of debt discount | | | - | | | | 40,830 | | Diluted income (loss) attributable to common shareholders | | $ | (524,784 | ) | | $ | (2,491,531 | ) | | | | | | | | | | Weighted average common shares outstanding – basic | | | 238,768,099 | | | | 230,062,215 | | Shares issuable upon conversion of convertible notes | | | - | | | | 5,908,980,584 | | Shares issuable upon conversion of Series B, C and D preferred stock | | | - | | | | - | | Weighted average common shares outstanding – diluted | | | 238,768,099 | | | | 6,139,042,799 | | | | | | | | | | | Net income (loss) per common share – basic | | $ | (0.00 | ) | | $ | 0.24 | | Net income (loss) per common share – diluted | | $ | (0.00 | ) | | $ | (0.00 | ) |
|